Quadrant Private Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Quadrant Private Wealth Management's REGN Position: Q3 2026 in Review
Quadrant Private Wealth Management opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2026: 325 shares worth $247K. The stake represents 0.03% of the portfolio and ranks #272 among its holdings. This is a return to the name: Quadrant Private Wealth Management previously reported a position in REGN as recently as Q4 2023.
Quadrant Private Wealth Management first reported a position in REGN in Q1 2023 and has held it in 4 quarters since. 1,425 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- Quadrant Private Wealth Management held 325 shares of Regeneron Pharmaceuticals worth $247K as of Q3 2026.
- Regeneron Pharmaceuticals was a new Quadrant Private Wealth Management position in Q3 2026.
- Regeneron Pharmaceuticals made up 0.03% of Quadrant Private Wealth Management's portfolio in Q3 2026, its #272 holding.
- Quadrant Private Wealth Management first reported a position in Regeneron Pharmaceuticals in Q1 2023 and has held it in 4 quarters since.
- 1,425 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on Quadrant Private Wealth Management's 13F filing for Q3 2026, filed 4 Nov 2026.